Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea · Delayed Price · Currency is KRW 2,260.00
-30.00 (-1.31%)
At close: Oct 2, 2026
Korea Arlico Pharm Market Cap
Korea Arlico Pharm has a market cap or net worth of 34.64 billion as of October 2, 2026. Its market cap has decreased by -44.40% in one year.
Market Cap
34.64B
Enterprise Value
54.81B
Revenue
195.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,260.00
ChartMarket Cap Chart
Since February 12, 2018, Korea Arlico Pharm's market cap has decreased from 207.83B to 34.64B, a decrease of -83.33%. That is a compound annual growth rate of -18.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 34.64B | -47.13% |
| Dec 30, 2025 | 65.52B | 23.73% |
| Dec 30, 2024 | 52.95B | -39.39% |
| Dec 28, 2023 | 87.36B | -12.98% |
| Dec 29, 2022 | 100.39B | -14.71% |
| Dec 30, 2021 | 117.71B | -17.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hwail Pharmaceutical | 54.10B |
| RP Bio | 51.48B |
| Jin Yang Pharmaceutical | 51.32B |
| Organoidsciences | 47.55B |
| GeneBioTech Co. ,Ltd | 42.54B |
| Kyung Nam Pharm | 39.44B |
| Eagle Veterinary Technology Co.,Ltd | 39.06B |
| Korean Drug | 35.41B |